Submitted: 15 Apr 2023
Accepted: 15 Jul 2023
ePublished: 04 Aug 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Prev Epidemiol. 2023;8(1): e35221.
doi: 10.34172/jpe.2023.35221
  Abstract View: 233
  PDF Download: 87

Mini Review

Podocyte infolding glomerulopathy; current concepts

Azadeh Khayyat 1 ORCID logo, Mohammad Ali Esmaeil Pour 2 ORCID logo, Hamid Nasri 3* ORCID logo

1 Pathology Department of Medical College of Wisconsin, Milwaukee, WI, USA
2 Internal Medicine Department of UNC Health Blue Ridge, Morganton, NC, USA
3 Nickan Research Institute, Isfahan, Iran
*Corresponding Author: Prof. Hamid Nasri, Email: hamidnasri@med.mui.ac.ir, , Email: hamidnasri@yahoo.com


Podocyte infolding glomerulopathy is a rare form of glomerular disease that can lead to proteinuria, chronic kidney disease, and end-stage renal disease. While the cause of podocyte infolding glomerulopathy is currently unknown, it is thought to be related to abnormalities in the glomerular basement membrane (GBM) structure and function. In this condition, the podocytes fold inward and form pockets or invaginations. This can lead to damage and scarring of the glomeruli, impairing kidney function. Diagnosis is typically made through clinical and laboratory tests, and treatment focuses on managing symptoms and slowing the progression of chronic kidney disease. Further research is needed to understand the pathophysiology of podocyte infolding glomerulopathy better and develop more effective treatments for this condition. Symptoms of podocyte infolding glomerulopathy may include proteinuria, hematuria, and decreased kidney function. Treatment options may include medications to control blood pressure and reduce proteinuria and immunosuppressive therapy to reduce inflammation and slow the progression of kidney damage.

Citation: Khayyat A, Esmaeil Pour MA, Nasri H. Podocyte infolding glomerulopathy; current concepts. J Prev Epidemiol. 2023;8(1):e35221. doi: 10.34172/ jpe.2023.35221.
First Name
Last Name
Email Address
Security code

Abstract View: 234

Your browser does not support the canvas element.

PDF Download: 87

Your browser does not support the canvas element.